CTLA-4 is not required for induction of CD8+ T cell anergy in vivo

Journal of Immunology

Volumn 167, Issue 9, 2001, Pages 4936-4941

  Frauwirth, K A ^a   Alegre, M L ^a   Thompson, C B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LIGAND; PEPTIDE; RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; GENETIC RECOMBINATION; IMMUNOREACTIVITY; IN VIVO STUDY; LIGAND BINDING; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 0035500781     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.9.4936     Document Type: Article

References (40)

1. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo
2. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: Specific induction of a long-lived state of proliferative nonresponsiveness
3. Inhibition of antigen-specific proliferation of type I murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody
4. 2-terminal kinase and mitogen-activated protein kinase signaling pathways
5. + T cells
6. + T cells
7. Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways
8. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo
9. Impaired Ca/ calcineurin pathway in in vivo anergized CD4 T cells
10. A population of in vivo anergized T cells with a lower activation threshold for the induction of CD25 exhibit differential requirements in mobilization of intracellular calcium and mitogen-activated protein kinase activation
11. Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rapl
12. Transactivation by AP-1 is a molecular target of T cell clonal anergy
13. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper I cells
14. + T cells have defective expression and function of the activating protein-1 transcription factor
15. Increased c-Fos/activator protein-1 confers resistance against anergy induction on antigen-specific T cell
16. CTLA-4 can function as a negative regulator of T cell activation
17. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
18. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement
19. CTLA-4 regulates tolerance induction and T cell differentiation in vivo
20. CTLA-4 is required for the induction of high dose oral tolerance
21. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival
22. Acquired thymic tolerance: Role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model
23. CTLA-4 regulates induction of anergy in vivo
24. + T cells
25. In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
26. Induction of alloantigen-specific hypo-responsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1
27. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2
28. Immunosuppression and induction of anergy by CTLA4 Ig in vitro: Effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis
29. B7-blocking agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory T cells
30. Analysis of the B7 costimulatory pathway in allograft rejection
31. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4
32. Induction of T cell anergy in the absence of CTLA-4/B7 interaction
33. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice
34. Anergic T cells as suppressor cells in vitro
35. Anergic T cells actively suppress T cell responses via the antigen-presenting cell
36. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
37. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
38. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
39. - T cells
40. + T cells